37 studies found for:    Open Studies | "Neuroma"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Neuroma"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation
Conditions: Neuroma;   Neuroma Amputation;   Pain
Interventions: Procedure: Targeted Muscle Reinnervation;   Procedure: Traction Neurectomy
2 Not yet recruiting Botulinum Toxin Type A for Neuroma Pain
Condition: Neuroma
Interventions: Drug: onabotulinum toxin type-A;   Other: placebo;   Drug: 2nd phase - onabotulinum toxin type-A
3 Unknown  Comparison of Alcohol and Steroid Injection for Treating Morton's Neuroma
Condition: Morton's Neuroma
Interventions: Drug: Injection of Steroid into Foot;   Drug: Injection of Alcohol into Foot;   Drug: Injection of Lidocaine into Foot
4 Unknown  Subtotal Resection of Large Acoustic Neuromas With Possible Stereotactic Radiation Therapy
Condition: Neuroma, Acoustic
Interventions: Procedure: Microsurgery;   Procedure: Stereotactic radiation therapy
5 Recruiting Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation
Conditions: Neuroma;   Pain;   Prosthesis User;   Prosthesis Failure
Intervention: Procedure: Targeted Muscle Reinnervation
6 Not yet recruiting Morton's Neuroma: Manipulation Versus Steroid Injection
Condition: Neuroma, Human Forefoot
Interventions: Drug: methylprednisolone;   Other: Manual manipulation
7 Recruiting A Study to Evaluate the Efficacy and Safety of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)
Condition: Painful Intermetatarsal Neuroma (Morton's Neuroma)
Intervention: Drug: CNTX-4975
8 Recruiting Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma
Conditions: Neurofibromatosis Type 2;   Neuroma, Acoustic
Intervention: Drug: RAD001, everolimus
9 Not yet recruiting Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma
Conditions: Vestibular Schwannoma;   Meningioma;   Acoustic Neuroma;   Neurofibromatosis Type 2
Intervention: Drug: AR-42
10 Recruiting Concentration and Activity of Lapatinib in Vestibular Schwannomas
Conditions: Vestibular Schwannoma;   NF2;   Neurofibromatosis 2;   Acoustic Neuroma;   Auditory Tumor
Intervention: Drug: lapatinib
11 Recruiting Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma
Conditions: Vestibular Schwannoma;   Acoustic Neuroma
Intervention: Radiation: Fractionated proton radiation
12 Recruiting Cyberknife Radiosurgery for Patients With Neurinomas
Conditions: Sporadic Acoustic Neuromas;   Useful Hearing
Intervention: Radiation: Radiosurgery
13 Recruiting Cochlear Implantation After Labyrinthectomy or a Translabyrinthine Surgical Approach
Conditions: Unilateral Acoustic Neuroma;   Meniere's Disease
Intervention: Device: Cochlear Implant
14 Unknown  Intraarterial Cerebral Infusion of Avastin for Vestibular Schwannoma (Acoustic Neuroma)
Condition: Vestibular Schwannoma
Intervention: Drug: Bevacizumab (Avastin)
15 Recruiting Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function
Condition: Vestibular Schwannoma
Intervention: Drug: Gentamicin
16 Recruiting Gentamicin Treatment Prior to Schwannoma Surgery - Residual Function
Condition: Vestibular Schwannoma
Intervention: Drug: Gentamicins
17 Recruiting Vestibular Schwannoma - Radiosurgery or Expectation: V-REX.
Condition: Vestibular Schwannoma
Intervention: Radiation: gamma knife radiosurgery
18 Recruiting Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
Conditions: Neurofibromatosis Type 2;   Vestibular Schwannomas
Intervention: Drug: Axitinib
19 Recruiting 18F-DOPA-PET in Planning Surgery in Patients With Gliomas
Conditions: Acoustic Schwannoma;   Adult Anaplastic (Malignant) Meningioma;   Adult Anaplastic Astrocytoma;   Adult Anaplastic Ependymoma;   Adult Anaplastic Oligodendroglioma;   Adult Brain Stem Glioma;   Adult Choroid Plexus Neoplasm;   Adult Craniopharyngioma;   Adult Diffuse Astrocytoma;   Adult Ependymoblastoma;   Adult Ependymoma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Grade I Meningioma;   Adult Grade II Meningioma;   Adult Medulloblastoma;   Adult Mixed Glioma;   Adult Myxopapillary Ependymoma;   Adult Oligodendroglioma;   Adult Papillary Meningioma;   Adult Pilocytic Astrocytoma;   Adult Pineal Gland Astrocytoma;   Adult Pineoblastoma;   Adult Pineocytoma;   Adult Primary Melanocytic Lesion of Meninges;   Adult Subependymal Giant Cell Astrocytoma;   Adult Subependymoma;   Childhood Cerebellar Anaplastic Astrocytoma;   Childhood Cerebellar Astrocytoma;   Childhood Cerebral Anaplastic Astrocytoma;   Childhood Cerebral Astrocytoma;   Childhood Choroid Plexus Neoplasm;   Childhood Craniopharyngioma;   Childhood Ependymoblastoma;   Childhood Grade I Meningioma;   Childhood Grade II Meningioma;   Childhood Grade III Meningioma;   Childhood Infratentorial Ependymoma;   Childhood Mixed Glioma;   Childhood Supratentorial Ependymoma;   Malignant Adult Intracranial Hemangiopericytoma;   Medulloepithelioma;   Newly Diagnosed Childhood Ependymoma;   Recurrent Adult Brain Neoplasm;   Recurrent Childhood Anaplastic Astrocytoma;   Recurrent Childhood Anaplastic Oligoastrocytoma;   Recurrent Childhood Anaplastic Oligodendroglioma;   Recurrent Childhood Brain Stem Glioma;   Recurrent Childhood Cerebellar Astrocytoma;   Recurrent Childhood Cerebral Astrocytoma;   Recurrent Childhood Diffuse Astrocytoma;   Recurrent Childhood Ependymoma;   Recurrent Childhood Fibrillary Astrocytoma;   Recurrent Childhood Gemistocytic Astrocytoma;   Recurrent Childhood Giant Cell Glioblastoma;   Recurrent Childhood Glioblastoma;   Recurrent Childhood Gliomatosis Cerebri;   Recurrent Childhood Gliosarcoma;   Recurrent Childhood Medulloblastoma;   Recurrent Childhood Oligoastrocytoma;   Recurrent Childhood Oligodendroglioma;   Recurrent Childhood Pilocytic Astrocytoma;   Recurrent Childhood Pilomyxoid Astrocytoma;   Recurrent Childhood Pineoblastoma;   Recurrent Childhood Pleomorphic Xanthoastrocytoma;   Recurrent Childhood Protoplasmic Astrocytoma;   Recurrent Childhood Subependymal Giant Cell Astrocytoma;   Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor;   Recurrent Childhood Visual Pathway Glioma;   Untreated Childhood Anaplastic Astrocytoma;   Untreated Childhood Anaplastic Oligoastrocytoma;   Untreated Childhood Anaplastic Oligodendroglioma;   Untreated Childhood Brain Stem Glioma;   Untreated Childhood Diffuse Astrocytoma;   Untreated Childhood Fibrillary Astrocytoma;   Untreated Childhood Gemistocytic Astrocytoma;   Untreated Childhood Giant Cell Glioblastoma;   Untreated Childhood Glioblastoma;   Untreated Childhood Gliomatosis Cerebri;   Untreated Childhood Gliosarcoma;   Untreated Childhood Medulloblastoma;   Untreated Childhood Oligoastrocytoma;   Untreated Childhood Oligodendroglioma;   Untreated Childhood Pilocytic Astrocytoma;   Untreated Childhood Pilomyxoid Astrocytoma;   Untreated Childhood Pineoblastoma;   Untreated Childhood Pleomorphic Xanthoastrocytoma;   Untreated Childhood Protoplasmic Astrocytoma;   Untreated Childhood Subependymal Giant Cell Astrocytoma;   Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor;   Untreated Childhood Visual Pathway Glioma
Interventions: Drug: Fluorine F 18 Fluorodopa;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography;   Procedure: Diffusion Weighted Imaging;   Procedure: Perfusion Magnetic Resonance Imaging;   Procedure: Therapeutic Conventional Surgery;   Procedure: Biopsy;   Other: Laboratory Biomarker Analysis
20 Unknown  A Study of Nilotinib in Growing Vestibular Schwannomas
Conditions: Volumetric Tumor Response and Lack of Tumor Progression;   Quality of Life of Patients on Nilotinib Versus Not
Intervention: Drug: Nilotinib

   Previous Page Studies Shown (1-20) Next Page (21-37) Show next page of results    Last Page
Indicates status has not been verified in more than two years